drugset / Trial / NCT04880512
The Safety, Tolerability, and Pharmacokinetics of SYHX1901 Tablets in Chinese Healthy Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This is a phase I clinical trial to evaluate the safety, tolerability and pharmacokinetic characteristics of single ascending doses and multiple ascending doses of SYHX1901 tablets in Chinese healthy subjects
Timeline
- Start
- 2021-05-31
- Primary completion
- 2022-08-20
- Completion
- 2022-12-20
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SYHX1901 | Unknown | — | Oral |
Indications
No indication recorded.